Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series
Marta Albanell‐Fernández, Inés Monge‐Escartín, E. Carcelero-San Martín, Gisela Riu Viladoms, Sonia Ruiz-Boy, Miquel Lozano, Dolors Soy, Ana Belén Moreno‐Castaño, Maribel Díaz‐Ricart, Joan Cid
Topics & Concepts
MedicineTolerabilityInternal medicineCohortAdverse effectCohort studyClinical trialPopulationRetrospective cohort studyInterquartile rangeEnvironmental healthComplement system in diseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaBlood groups and transfusion